United States Cardiovascular Devices Market Report by Device Type, Application, End User, States and Company Analysis 2026-2034

United States Cardiovascular Devices Market Size & Forecast 2026-2034

United States Cardiovascular Devices Market is expected to reach US$ 18.79 Billion in 2025 from US$ 32.62 Billion in 2034, with a Compound Annual Growth Rate (CAGR) of 6.32% from 2026-2034. This is due to the increasing prevalence of cardiovascular diseases, the aging population, and the demand for minimally invasive procedures. Advancements in diagnostic and therapeutic devices, along with the strong healthcare infrastructure and favorable reimbursement environment, are also contributing to the growth of the market.

United States Cardiovascular Devices Market Outlook

Cardiovascular devices are medical instruments used for the diagnosis, monitoring, and treatment of diseases associated with the heart and blood vessels. Examples of cardiovascular devices include pacemakers, stents, defibrillators, catheters, heart valves, and cardiac monitoring systems. These devices are used to treat conditions such as coronary artery disease, heart failure, arrhythmias, and blocked arteries. Some of these devices are implantable, offering long-term relief for patients with heart problems, while others are employed in medical diagnostics to monitor the heart's health.

In the United States, cardiovascular devices are very common owing to the widespread nature of heart disease, which is one of the leading causes of death. The rising age of the population, sedentary lifestyle, and rising cases of obesity, high blood pressure, and diabetes have all contributed to the increased use of these devices. Furthermore, the advanced healthcare system, technological advancements, and the availability of minimally invasive procedures have all improved treatment outcomes. There is also greater awareness, early diagnosis, and preventive measures that have all contributed to the widespread use of cardiovascular devices in the United States.

Growth Drivers of the USA Cardiovascular Devices Market

Rising Prevalence of Cardiovascular Diseases

Cardiovascular diseases are the major cause of deaths worldwide, claiming a staggering 17.9 million lives annually. One of the major drivers of the USA cardiovascular devices market is the rising incidence of cardiovascular diseases such as coronary artery disease, heart failure, and arrhythmias. Sedentary lifestyle, unhealthy eating habits, obesity, smoking, and rising stress levels have contributed substantially to the risk of heart-related ailments. Moreover, chronic diseases such as diabetes and hypertension also add to the cardiovascular problems. With the rising number of patients being diagnosed with heart ailments, the need for cardiovascular devices for diagnosis and treatment is also rising. Cardiovascular devices are of utmost importance in the early diagnosis, monitoring, and successful treatment of patients. Hospitals and healthcare service providers are increasingly using advanced cardiovascular technology to improve patient care. It is estimated that 20% of the population of the world is expected to become 65 years or older, and by the year 2030, the number of deaths due to CVDs is expected to increase from 16.7 million in 2002 to 23.3 million, including a substantial rise in low- and middle-income countries such as India.

Technological Advancements and Innovation

Advancements in technology have been a major factor in the development of the cardiovascular devices market in the United States. Innovation has led to the development of advanced technologies like implantable pacemakers, wearable heart monitors, minimally invasive catheters, and drug-eluting stents. These advanced technologies provide greater accuracy, improved patient comfort, and quicker recovery times than traditional treatments. Minimally invasive procedures have gained immense popularity due to the reduced hospital stay times, lower risks of complications, and increased efficiency of treatments. Moreover, the use of digital technologies such as remote monitoring and wireless connectivity enables healthcare professionals to remotely monitor patients. This enhances the early detection of possible complications and enables timely medical assistance. The presence of top medical device companies and high investments in research and development activities further aid in innovation. Dec 2025, vTitan Corporation, a MedTech firm with a focus on innovative healthcare solutions, announced the launch of vCardio, a single-lead, wearable point-of-care cardiac monitor. The product is completely developed and made in India, making vTitan one of the first firms in the country to provide an end-to-end solution from hardware to cloud-based AI analytics in the health-tech domain.

Aging Population and Increased Healthcare Spending

The population of Americans aged 65 years and older is expected to rise by more than double in the next 40 years, reaching 80 million in 2040. The population of adults aged 85 years and older, who are most likely to require assistance with basic personal care, is expected to nearly quadruple between 2000 and 2040. The aging population in the United States is another significant driver for the cardiovascular devices market. Older adults are more susceptible to heart diseases due to natural aging, reduced heart function, and increased susceptibility to chronic diseases. With the increasing elderly population in the United States, the demand for cardiovascular diagnostic and treatment devices is rising substantially. In addition, the United States has one of the highest levels of healthcare expenditure in the world, which enables healthcare providers to invest in the latest medical technologies. Easy access to healthcare services, health screenings, and preventive healthcare have resulted in the early diagnosis and treatment of heart diseases. Government-sponsored healthcare programs and insurance coverage have also made cardiovascular devices more accessible to patients.

Challenges of the USA Cardiovascular Devices Market

High Cost of Cardiovascular Devices and Procedures

One of the biggest challenges in the USA cardiovascular devices market is the high cost that is associated with these devices and the medical procedures. Advanced cardiovascular devices like implantable defibrillators, pacemakers, and stents can be costly, and this will increase the cost of treatment. Apart from the cost of the devices, patients will also have to pay for hospital fees, surgery, and post-surgery costs. These costs can be a challenge, especially for patients who do not have adequate insurance to cover the costs of treatment. Healthcare providers and hospitals will also have to deal with budget constraints when it comes to investing in advanced medical technologies. The increasing cost of healthcare services will also be a challenge to insurance companies and government health programs. The cost of treatment may affect the use of newer and more advanced devices, especially in smaller healthcare facilities.

Strict Regulatory Requirements and Approval Processes

The cardiovascular devices market in the United States is regulated by stringent regulations to ensure the safety of patients and the efficacy of the devices. The regulatory bodies demand extensive clinical testing and approval before the devices can be launched in the market. This may be a time-consuming and costly process, which may delay the launch of products in the market. Manufacturers have to invest heavily in research and development to comply with the regulations. Moreover, any defects or safety issues with the devices may lead to product recalls, lawsuits, and loss of reputation. Small companies may find it difficult to comply with the regulations owing to financial and technical constraints. Although these regulations are critical to ensure patient safety, they may hinder innovation and the adoption of new technologies. Compliance with complex regulations is a significant challenge for cardiovascular device manufacturers in the United States.

USA Cardiovascular Diagnostic and Monitoring Devices Market

The USA cardiovascular diagnostic and monitoring devices market is expanding at a rapid pace due to the rising demand for early diagnosis and effective management of heart-related disorders. These devices include electrocardiograms (ECG), Holter monitors, cardiac event monitors, and wearable heart monitoring systems. These devices enable healthcare providers to monitor irregular heart rhythms, monitor heart activity, and evaluate overall cardiovascular health. The rising incidence of chronic diseases like hypertension, diabetes, and obesity has led to a growing need for heart monitoring. Moreover, technological innovations like portable and wearable devices have enhanced patient convenience and enabled continuous heart monitoring outside healthcare facilities. Remote patient monitoring has gained immense popularity, enabling healthcare providers to monitor patient conditions in real-time and take timely actions. Increasing awareness regarding preventive healthcare and regular heart screenings is also fueling market growth. Since early diagnosis is essential for preventing severe complications, the demand for cardiovascular diagnostic and monitoring devices is rising.

USA Cardiac Arrhythmia Devices Market

The USA market for cardiac arrhythmia devices is growing due to the rising number of cases of irregular heartbeats, such as atrial fibrillation and bradycardia. If these conditions are not treated, they can cause severe complications like stroke and heart failure. Cardiac arrhythmia devices like pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices are used to control irregular heartbeats and improve heart function. The rising geriatric population is prone to irregular heartbeats, thereby fueling the demand for these devices. Advances in technology have improved the efficiency, safety, and battery life of these devices, leading to improved patient outcomes. The development of minimally invasive procedures for implanting these devices has also improved patient acceptance and shortened recovery periods. Furthermore, increased awareness, early diagnosis, and easy access to advanced healthcare facilities have also driven the market. With the increasing incidence of arrhythmia, the demand for efficient cardiac rhythm management devices is expected to rise steadily in the USA.

USA Heart Failure Devices Market

The USA heart failure devices market is growing rapidly because of the rising number of patients suffering from heart failure. Heart failure is a condition where the heart is unable to pump blood effectively. This results in symptoms such as fatigue, shortness of breath, and decreased quality of life. Heart failure devices such as ventricular assist devices (VADs), implantable cardiac resynchronization therapy devices, and heart pumps are used to improve the functioning of the heart and provide relief to patients suffering from severe heart conditions. The rising number of elderly people and the rising prevalence of chronic diseases such as diabetes and hypertension have increased the risk of heart failure. Advances in technology have resulted in the development of smaller, more efficient devices that are safer and more effective. Furthermore, increased awareness about the availability of advanced treatment solutions and better access to specialized cardiac care have also contributed to the growth of the market. Heart failure continues to be a significant concern for people's health, and as a result, there is a growing demand for sophisticated cardiovascular support devices in the USA.

USA Cardiovascular Devices Hospitals and Clinics Market

Hospitals and clinics are the biggest end-users of cardiovascular devices in the United States because of the country's advanced medical infrastructure and specialized facilities for cardiac care. The medical facilities use a variety of devices for the diagnosis, treatment, and monitoring of cardiovascular diseases. The hospitals have advanced surgical facilities and trained medical staff to perform complex procedures like stent implantation, pacemaker implantation, and heart valve replacement. The clinics also have an important role in monitoring, diagnosis, and follow-up treatment. Rising admissions of patients with cardiovascular diseases and the need for minimally invasive procedures are fueling the demand for devices in hospitals and clinics. Hospitals and clinics are also adopting new technologies to improve patient outcomes and increase the efficiency of treatments. The advanced healthcare infrastructure, insurance, and availability of specialized care are still fueling the adoption of cardiovascular devices in hospitals and clinics.

USA Cardiovascular Devices Diagnostic Centers Market

Diagnostic centers are very important for the early diagnosis and subsequent monitoring of cardiovascular diseases in the United States. These centers are equipped with modern diagnostic equipment like ECG machines, stress testing machines, and cardiac imaging systems. They offer important services for the early detection of heart conditions, which enables early medical intervention and treatment. There has been increased awareness of preventive healthcare and health checkups, leading to increased patient flow to diagnostic centers. These centers provide cost-effective and accessible diagnostic services, relieving hospitals of the burden. Moreover, advancements in technology have enhanced the accuracy and efficiency of diagnostic processes, improving patient care. Many diagnostic centers also offer outpatient monitoring services, enabling continuous monitoring of heart conditions. With the growing importance of preventive healthcare, the role of diagnostic centers in managing cardiovascular diseases is also increasing, thereby fueling the demand for cardiovascular diagnostic equipment.

California Cardiovascular Devices Market

California is one of the biggest markets for cardiovascular devices in the United States, given its large population and well-developed healthcare facilities. The state has a high incidence of cardiovascular diseases due to the increasing age of the population, a sedentary lifestyle, and prevalent conditions such as obesity and diabetes. The major hospitals, research centers, and cardiac care facilities in California are equipped with the latest diagnostic and treatment facilities, thereby fueling demand for cardiovascular devices. The state also has the presence of major medical device manufacturers and innovation centers, which promotes advancements and early adoption of new technologies in cardiovascular devices. In addition, the growing awareness of preventive healthcare and regular heart screenings has led to early diagnosis and treatment. Heavy investments in the development of healthcare services and the availability of specialized cardiac care facilities also support market growth. In June 2024, AliveCor introduced the Kardia 12L ECG System, which uses AI technology to identify 35 types of cardiac diseases with a reduced lead, thereby changing the face of cardiac care. These factors make the devices more effective, safe, and user-friendly, thereby increasing demand for advanced cardiovascular technologies and hence fueling the U.S. cardiovascular device market.

New York Cardiovascular Devices Market

The market for cardiovascular devices in New York is growing because of its large population and the need for sophisticated healthcare. The state has many hospitals, cardiac centers, and academic medical centers that offer sophisticated care for cardiovascular patients. The large number of cardiovascular patients, especially in urban areas, has driven the demand for diagnostic and therapeutic equipment. Lifestyle factors such as stress, physical inactivity, and unhealthy eating habits also increase the risk of heart disease. Moreover, the sophisticated healthcare infrastructure in New York facilitates early diagnosis, minimally invasive procedures, and sophisticated cardiac care. The presence of top-notch healthcare facilities and research centers also encourages innovation and the adoption of sophisticated cardiovascular technology. Government support, insurance coverage, and healthcare awareness also help in the growth of the market. With the increasing demand for quality cardiac care, New York is a major market for cardiovascular devices. In March 2025, Abbott received CE Mark approval for its Volt Pulsed Field Ablation System, which is specifically designed for the treatment of patients with arrhythmia. This device employs cutting-edge pulsed field ablation technology to selectively destroy cardiac tissue, providing a new treatment paradigm for managing irregular heart rhythms.

Washington Cardiovascular Devices Market

The market for cardiovascular devices in Washington is steadily growing due to increased investment in the healthcare sector and growing awareness about heart health. The state has a well-developed healthcare infrastructure with advanced cardiac diagnostic and treatment facilities. There is growing awareness about preventive healthcare and regular medical check-ups, which has led to an increase in the demand for cardiovascular monitoring devices. In addition, the growing geriatric population and rising cases of chronic diseases such as hypertension and diabetes are also fueling the growth of the market. Healthcare organizations in Washington are increasingly resorting to the use of advanced cardiovascular devices to improve patient outcomes and treatment efficiency. The state's emphasis on innovative healthcare solutions and digital healthcare technology is also aiding the adoption of remote monitoring and wearable cardiovascular devices. There is also strong collaboration between healthcare organizations and technology companies, which is further aiding the growth of the market. In November 2024, Johnson & Johnson MedTech received FDA approval for the VARIPULSE Pulsed Field Ablation (PFA) system, which is specifically designed for the ablation of atrial fibrillation (AF).

Massachusetts Cardiovascular Devices Market

Massachusetts represents a major market for cardiovascular devices because of its excellent healthcare infrastructure and globally acclaimed research institutions. The region boasts of the best hospitals, academic medical institutions, and biotech firms that promote innovation in cardiac care. These organizations actively embrace the latest cardiovascular devices for diagnostic, therapeutic, and research applications. The rising incidence of cardiovascular disorders and the aging population have led to an increase in the demand for cardiac care services. Moreover, the region is known for its emphasis on medical research and technology development, which helps in the development and acceptance of innovative cardiovascular devices. The availability of quality healthcare services and specialized cardiac care centers also helps in the development of the market. In January 2024, Boston Scientific received FDA approval for the FARAPULSE Pulsed Field Ablation System, which is a major breakthrough in the ablation technology segment. The FARAPULSE Pulsed Field Ablation System uses pulsed field ablation (PFA), a revolutionary technology that employs non-thermal energy to specifically target cardiac tissue, thereby avoiding damage to surrounding tissues.

Market Segmentation

Device type

• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices

Application

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers
• Cardiac Catheterization Laboratories
• Others

States

• California
• Texas
• New York
• Florida
• Illinois
• Pennsylvania
• Ohio
• Georgia
• New Jersey
• Washington
• North Carolina
• Massachusetts
• Virginia
• Michigan
• Maryland
• Colorado
• Tennessee
• Indiana
• Arizona
• Minnesota
• Wisconsin
• Missouri
• Connecticut
• South Carolina
• Oregon
• Louisiana
• Alabama
• Kentucky
• Rest of the United States

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Competitive Landscape

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences
• Cardinal Health Inc.
• Medtronic PLC
• GE Healthcare
• Johnson & Johnson Services, Inc.
• Siemens Healthcare GmbH.